ANDA 90145, held by Novel Labs Inc. Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate.
As of Nov 16, 2026, ANDA 90145 (Peg-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate And Ascorbic Acid), held by Novel Labs Inc, was first approved by FDA on Jan 25, 2012, with 2 approved supplements and 0 published complete response letters.
PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 25, 2012 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Peg-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate And Ascorbic Acid4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM · for solution;oral | Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate | Rx |
| Dec 17, 2019 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jun 13, 2012 | Supplement 1Labeling | Approved | None posted |
| Jan 25, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters